Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
FLGT
#2925
Fulgent Genetics, Inc. Common Stock
16.020
0
USD
+4.71%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+4.71%
Aylık Değişim
+7.81%
6 aylık değişim
-32.20%
Yıllık Değişim
-32.20%
Önceki Kapanış
15.300
0
Open
16.020
0
Bid
Ask
Low
16.020
0
High
16.020
0
Hacim
107
Piyasalar
ABD Borsası
Sağlık Hizmetleri
FLGT
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
28.87 M
30.25 M
29.52 M
29.78 M
30.83 M
31.23 M
—
Valuation ratios
Enterprise value
1.42 B
2.9 B
849.3 M
787.36 M
518.68 M
772.64 M
2.33 B
Price to earnings ratio
5.85
6.14
6.62
-5.2
-13.1
-13.34
-54.28
Price to sales ratio
2.97
3.14
1.53
3.02
1.97
2.51
8.45
Price to cash flow ratio
8.91
5.79
3.74
32.31
26.52
-7.95
416.42
Price to book ratio
2.2
2.69
0.75
0.77
0.49
0.73
1.13
Enterprise value to EBITDA ratio
4.83
4.2
3.92
-4.56
-10.41
-11.42
-43.61
Profitability ratios
Return on assets %
0.31
0.4
0.1
-0.14
-0.04
-0.05
-0.05
Return on equity %
0.38
0.44
0.11
-0.15
-0.04
-0.05
-0.05
Return on invested capital %
411.36
278.27
47.19
-67
-22.53
-32.94
-31.41
Gross margin %
78.7
78.29
59.28
36.12
37.82
40.56
162.02
Operating margin %
68.8
68.1
28.84
-67.61
-26.08
-28.23
-112.79
EBITDA margin %
69.51
69.21
34.12
-58.57
-17.28
-20.76
-82.81
Net margin %
50.82
51.12
23.17
-58.03
-15.07
-18.75
-74.83
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
4.02
5.81
7.13
6.96
4.85
6.48
25.82
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
1.07
1
0.46
0.22
0.23
0.27
0.27
Solvency ratios
Debt to assets ratio
—
0.01
0.01
0.01
0.01
0.01
0.03
Debt to equity ratio
—
0.01
0.02
0.01
0.01
0.01
0.03
Long term debt to total assets ratio
—
0
0
0
0
0
0.01
Long term debt to total equity ratio
—
0.01
0
0
0
0
0.01
Per share metrics
Operating cash flow per share
5.85
17.39
8.19
0.91
0.7
-3.3
-3.31
EBIT per share
12.06
21.82
5.77
-6.56
-2.44
-2.96
-2.96
EBITDA per share
12.18
22.18
6.82
-5.69
-1.62
-2.18
-2.18
Total debt per share
—
0.43
0.66
0.51
0.28
0.25
0.98
Cash per share
12.44
5.32
2.57
3.27
1.82
10.92
19.8
Net current asset value per share
21.77
19.76
20.28
17.05
11.69
17.89
61.94
Tangible book value per share
23.67
34.61
31.42
32.6
32.29
30.99
125.46
Working capital per share
16.36
16.36
17.43
14.6
9.28
15.13
52.35
Book value per share
23.67
37.41
40.91
38.14
37.48
36.13
145.86
Haberler
Fulgent Genetics 56,9 milyon dolarlık patoloji laboratuvarı satın alımlarını tamamladı
Oracle Q3 Earnings On Deck; Inflation, Jobs Data Also In Focus
Netflix, Dell among market cap stock movers on Friday
Netflix and Dell among market cap stock movers on Friday
Fulgent 4Ç 2025: Hisse başı kazanç beklentiyi aştı ama müşteri kaybı hisseyi vurdu
Fulgent Q4 2025 slides: EPS beats, but customer loss drives stock plunge
Fulgent Genetics, Inc. (FLGT) Q4 Earnings Top Estimates
Fulgent Genetics earnings beat by $0.22, revenue fell short of estimates
Brightspring Health Services, BASF, Swiss Re and more set to report Friday
Cheniere Energy to Report Q4 Earnings: What's in the Offing?
Doximity (DOCS) Q3 Earnings and Revenues Surpass Estimates
Fulgent Genetics (FLGT): The Price Has Caught Up To Value, But I Still Like The Stock